Victory Capital Management Inc Madrigal Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

A detailed history of Victory Capital Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 2,252 shares of MDGL stock, worth $488,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,252

Previous 2,128 5.83%

Holding current value

$488,684

Previous $568,000 10.92%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$193.33 - $291.99 $23,972 - $36,206	124 Added 5.83%	2,252 $630,000
Q1 2024 May 03, 2024	BUY	$171.37 - $283.23 $35,644 - $58,911	208 Added 10.83%	2,128 $568,000
Q4 2023 Feb 05, 2024	BUY	$120.4 - $237.13 $60,079 - $118,327	499 Added 35.12%	1,920 $444,000
Q3 2023 Nov 06, 2023	SELL	$146.04 - $225.78 $188,829 - $291,933	-1,293 Reduced 47.64%	1,421 $207,000
Q2 2023 Jul 27, 2023	SELL	$203.88 - $312.0 $32,416 - $49,608	-159 Reduced 5.53%	2,714 $626,000
Q1 2023 May 02, 2023	BUY	$231.06 - $307.08 $340,813 - $452,943	1,475 Added 105.51%	2,873 $696,000
Q4 2022 Feb 10, 2023	BUY	$58.39 - $296.54 $759 - $3,855	13 Added 0.94%	1,398 $405,000
Q4 2022 Feb 09, 2023	BUY	$58.39 - $296.54 $80,870 - $410,707	1,385 New	1,385 $401,000
Q2 2020 Aug 07, 2020	SELL	$60.13 - $125.71 $99,274 - $207,547	-1,651 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$66.76 - $93.49 $11,616 - $16,267	-174 Reduced 9.53%	1,651 $110,000
Q4 2019 Feb 06, 2020	BUY	$84.28 - $118.5 $29,413 - $41,356	349 Added 23.64%	1,825 $166,000
Q4 2019 Feb 04, 2020	BUY	$84.28 - $118.5 $421 - $592	5 Added 0.34%	1,476 $123,000
Q3 2019 Nov 12, 2019	BUY	$84.4 - $106.53 $124,152 - $156,705	1,471 New	1,471 $127,000
Q2 2019 Aug 15, 2019	SELL	$91.13 - $142.5 $1.81 Million - $2.83 Million	-19,885 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$103.48 - $143.84 $710,907 - $988,180	6,870 Added 52.79%	19,885 $2.49 Million
Q4 2018 Feb 05, 2019	SELL	$94.77 - $215.54 $17.1 Million - $38.9 Million	-180,683 Reduced 93.28%	13,015 $1.47 Million
Q3 2018 Nov 01, 2018	BUY	$207.3 - $300.31 $1.96 Million - $2.84 Million	9,451 Added 5.13%	193,698 $41.5 Million
Q2 2018 Aug 02, 2018	SELL	$101.55 - $313.9 $1.9 Million - $5.88 Million	-18,735 Reduced 9.23%	184,247 $51.5 Million
Q1 2018 May 04, 2018	SELL	$93.35 - $149.04 $114,260 - $182,424	-1,224 Reduced 0.6%	202,982 $23.7 Million
Q4 2017 Feb 01, 2018	BUY	$39.35 - $97.37 $6.05 Million - $15 Million	153,650 Added 303.92%	204,206 $18.7 Million
Q3 2017 Oct 27, 2017	BUY	$15.48 - $46.19 $782,606 - $2.34 Million	50,556	50,556 $2.27 Million

Others Institutions Holding MDGL

# of Institutions

299

Shares Held

22M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.71B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Madrigal Pharmaceuticals, Inc. Transaction History